Live Quote · NASDAQRXSTHealthcare· Medical - Devices

RxSight, Inc.

$5.61 8.51%(+$0.44)
TickerSpark Score
49/100
Weak
80
Valuation
40
Profitability
15
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RXST research report →

52-Week Range13% of range
Low
$4.48
Current
$5.61
High
$13.36
Company Overviewwww.rxsight.com

About the company

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs).

CEO
Ronald Kurtz
IPO
2021
Employees
498
HQ
Aliso Viejo, CA, US

Price Chart

-57.31% · this period
$13.14$8.87$4.59Jul 02Dec 31Jul 02
Valuation
Market Cap
$232.23M
P/E
-4.96
P/S
1.82
P/B
0.87
EV/EBITDA
-5.21
Div Yield
0.00%
Profitability
Gross Margin
77.02%
Op Margin
-43.42%
Net Margin
-36.58%
ROE
-17.01%
ROIC
-19.90%
Growth & Income
Revenue
$134.48M · -3.89%
Net Income
$-38,943,000 · -41.84%
EPS
$-0.95 · -33.80%
Op Income
$-48,190,000
FCF YoY
13.60%
Performance & Tape
52W High
$13.36
52W Low
$4.48
50D MA
$5.73
200D MA
$8.18
Beta
1.13
Avg Volume
981.75K

Get TickerSpark's AI analysis on RXST

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 17, 26Warner Robert Keithother37,037
Jun 17, 26PALMISANO ROBERT Jother37,037
Jun 17, 26Maniar Shwetaother37,037
Jun 17, 26Fountain Tamaraother37,037
Jun 17, 26LINK WILLIAM J PHDother37,037
Jun 17, 26Corley Jesse Andersonother37,037
Jun 17, 26COHEN RAYMOND Wother30,864
Jun 17, 26Tammenoms Bakker Julietother37,037
Jun 17, 26Andrews Julieother37,037
Apr 17, 26Goldshleger Ilyaother12,489
Coverage · RXST

Our RXST coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on RXST yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate RXST report →
Internal Compare

Similar companies

Peers in the same neighborhood.